glp-1 thyroid cancer Glucagon-like peptide 1 receptor agonist use and risk of cancer: Scandinavian cohort study GLP-1 Agonists: The Medical Revolution

MTHFR-impaired SAMe limits COMT activity increasing catechol estrogen dwell time and quinone formation risk, raising the demand on GSTM1/GSTT1 as the backup

Systemic proteome adaptions to 7-day complete caloric restriction in humans

Alogliptin, a dipeptidylpeptidase-4 inhibitor, for patients with diabetes mellitus type 2, induces tolerance to focal cerebral ischemia in non-diabetic, normal mice

Pennsylvania restricts weight-loss drugs for Medicaid patients amid budget woes

Additionally, various combinations of incretin-based therapies such as Cagrisema and Retatrutide have entered phase III clinical trials, with early data suggesting they may offer an even greater degree of weight reduction benefits

The peptide stack can also be used perioperatively to improve surgical outcomes and reduce recovery time